An epidemic of the use, misuse and overdose of opioids and deaths due to overdose, in the United States and Canada

Bone and Joint Journal

Volumn 99B, Issue 7, 2017, Pages 856-864

  Helmerhorst, G T T ^a   Teunis, T ^a,b   Janssen, S J ^a,c   Ring, D ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE; NARCOTIC ANALGESIC AGENT;

ANALGESIA; ATTITUDE TO ILLNESS; CANADA; COMPARATIVE STUDY; COPING BEHAVIOR; DRUG INDUSTRY; DRUG MARKETING; DRUG MISUSE; DRUG OVERDOSE; DRUG SAFETY; DRUG USE; EUROPE; HUMAN; MORTALITY; NOCICEPTION; PAIN; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; STANDARD; UNITED KINGDOM; UNITED STATES; EPIDEMIOLOGY; FEMALE; MALE; OPIATE ADDICTION; STATISTICS AND NUMERICAL DATA;

ANALGESICS, OPIOID; CANADA; DRUG OVERDOSE; FEMALE; HUMANS; MALE; OPIOID-RELATED DISORDERS; PRESCRIPTION DRUG MISUSE; UNITED STATES;

EID: 85021641977     PISSN: 20494394     EISSN: 20494408     Source Type: Journal    
DOI: 10.1302/0301-620X.99B7.BJJ-2016-1350.R1     Document Type: Review

References (112)

1. Van Zee A. The promotion and marketing of oxycontin: commercial triumph, public health tragedy. Am J Public Health 2009;99:221-227.
2. Kolodny A, Courtwright DT, Hwang CS, et al. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu Rev Public Health 2015;36:559-574.
3. No authors listed. US General Accounting Office. Prescription drugs: oxycontin abuse and diversion and efforts to address the problem. http://www.gao.gov/ new.items/d04110.pdf (date last accessed 21 March 2017).
4. Clarke TC, Nahin RL, Barnes PM, Stussman BJ. Use of complementary health approaches for musculoskeletal pain disorders among adults: united states, 2012. Natl Health Stat Report 2016;98:1-12.
5. Institute of Medicine (US) Committee on Advancing Pain Research, Care, and Education. Relieving pain in america: a blueprint for transforming prevention, care, education, and research. Washington: National Academies Press (US); 2011.
6. Pizzo PA, Clark NM. Alleviating suffering 101-pain relief in the United States. N Engl J Med 2012;366:197-199.
7. Vranceanu AM, Bachoura A, Weening A, et al. Psychological factors predict disability and pain intensity after skeletal trauma. J Bone Joint Surg [Am] 2014;96-A:20.
8. Severeijns R, Vlaeyen JW, van den Hout MA, Weber WE. Pain catastrophizing predicts pain intensity, disability, and psychological distress independent of the level of physical impairment. Clin J Pain 2001;17:165-172.
9. Menendez ME, Ring D. Factors Associated with Greater Pain Intensity. Hand Clin 2016;32:27-31.
10. Veehof MM, Trompetter HR, Bohlmeijer ET, Schreurs KM. Acceptance- and mindfulness-based interventions for the treatment of chronic pain: a meta-analytic review. Cogn Behav Ther 2016;45:5-31.
11. Helmerhorst GT, Lindenhovius AL, Vrahas M, Ring D, Kloen P. Satisfaction with pain relief after operative treatment of an ankle fracture. Injury 2012;43:1958-1961.
12. Bot AG, Bekkers S, Arnstein PM, Smith RM, Ring D. Opioid use after fracture surgery correlates with pain intensity and satisfaction with pain relief. Clin Orthop Relat Res 2014;472:2542-2549.
13. Nota SP, Spit SA, Voskuyl T, et al. Opioid Use, Satisfaction, and Pain Intensity After Orthopedic Surgery. Psychosomatics 2015;56:479-485.
14. Helmerhorst GT, Vranceanu AM, Vrahas M, Smith M, Ring D. Risk factors for continued opioid use one to two months after surgery for musculoskeletal trauma. J Bone Joint Surg [Am] 2014;96-A:495-499.
15. Moore D. Heroin: a brief history of unintended consequences. http://www.timesunion. com/518life/article/Heroin-A-brief-history-of-unintended-consequences- 5705610.php (date last accessed 21 March 2017).
16. MacLaren E. Heroin History and Statistics. http://drugabuse.com/library/heroin-history- and-statistics/ (date last accessed 16 May 2017).
17. Rudd RA, Seth P, David F, Scholl L. Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010-2015. MMWR Morb Mortal Wkly Rep 2016;65:1445-1452.
18. No authors listed. Centers for Disease Control and Prevention (CDC). Wide-ranging online data for epidemiologic research (WONDER). https://wonder.cdc.gov/ (date last accessed 21 March 2017).
19. No authors listed. International Narcotics Control Board (INCB). Estimated world requirements of narcotic drugs in grams for 2016; October update. https:// www.incb.org/incb/en/narcotic-drugs/estimates/nacotic-drugs-estimates.html (date last accessed 21 March 2017).
20. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 2006;10:287-333.
21. Schubert I, Ihle P, Sabatowski R. Increase in opiate prescription in Germany between 2000 and 2010: a study based on insurance data. Dtsch Arztebl Int 2013;110:45-51.
22. Giraudon I, Lowitz K, Dargan PI, Wood DM, Dart RC. Prescription opioid abuse in the UK. Br J Clin Pharmacol 2013;76:823-824.
23. Beauchamp GA, Winstanley EL, Ryan SA, Lyons MS. Moving beyond misuse and diversion: the urgent need to consider the role of iatrogenic addiction in the current opioid epidemic. Am J Public Health 2014;104:2023-2029.
24. Davis CS, Carr D. Physician continuing education to reduce opioid misuse, abuse, and overdose: many opportunities, few requirements. Drug Alcohol Depend 2016;163:100-107.
25. Bohnert AS, Valenstein M, Bair MJ, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA 2011;305:1315-1321.
26. Wisniewski AM, Purdy CH, Blondell RD. The epidemiologic association between opioid prescribing, non-medical use, and emergency department visits. J Addict Dis 2008;27:1-11.
27. No authors listed. The National Center on Addiction and Substance Abuse at Columbia University (CASA). Under the counter. the diversion and abuse of controlled prescription drugs in the U.S. 2005. https://www.centeronaddiction.org/sites/ default/files/Under-the-counter-the-diversion-and-abuse-of-controlled-prescriptiondrugs- in-the-us-0.pdf (date last accessed 21 March 2017).
28. Chapman CR, Lipschitz DL, Angst MS, et al. Opioid pharmacotherapy for chronic non-cancer pain in the United States: a research guideline for developing an evidence- base. J Pain 2010;11:807-829.
29. Inciardi JA, Surratt HL, Cicero TJ, Beard RA. Prescription opioid abuse and diversion in an urban community: the results of an ultrarapid assessment. Pain Med 2009;10:537-548.
30. Inciardi JA, Surratt HL, Lugo Y, Cicero TJ. The Diversion of Prescription Opioid Analgesics. Law Enforc Exec Forum 2007;7:127-141.
31. Cicero TJ, Kurtz SP, Surratt HL, et al. Multiple Determinants of Specific Modes of Prescription Opioid Diversion. J Drug Issues 2011;41:283-304.
32. Porter J, Jick H. Addiction rare in patients treated with narcotics. N Engl J Med 1980;302:123.
33. Noble M, Treadwell JR, Tregear SJ, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev 2010;2010:CD006605.
34. No authors listed. The American Academy of Pain Medicine and the American Pain Society. The use of opioids for the treatment of chronic pain. A consensus statement from the American Academy of Pain Medicine and the American Pain Society. Clin J Pain 1997;13:6-8.
35. Portenoy RK, Foley KM. Chronic use of opioid analgesics in non-malignant pain: report of 38 cases. Pain 1986;25:171-186.
36. Fishbain DA, Cole B, Lewis J, Rosomoff HL, Rosomoff RS. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence- based review. Pain Med 2008;9:444-459.
37. Martell BA, O'Connor PG, Kerns RD, et al. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med 2007;146:116-127.
38. Boscarino JA, Rukstalis MR, Hoffman SN, et al. Prevalence of prescription opioid- use disorder among chronic pain patients: comparison of the DSM-5 vs. DSM-4 diagnostic criteria. J Addict Dis 2011;30:185-194.
39. Zin CS, Chen LC, Knaggs RD. Changes in trends and pattern of strong opioid prescribing in primary care. Eur J Pain 2014;18:1343-1351.
40. Boudreau D, Von Korff M, Rutter CM, et al. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf 2009;18:1166-1175.
41. Manchikanti L, Helm S 2nd, Fellows B, et al. Opioid epidemic in the United States. Pain Physician 2012;15:ES9-E38.
42. Chou R, Turner JA, Devine EB, et al. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med 2015;162:276-286.
43. da Costa BR, Nuesch E, Kasteler R, et al. Oral or transdermal opioids for osteoarthritis of the knee or hip. Cochrane Database Syst Rev 2014;9:CD003115.
44. Chaparro LE, Furlan AD, Deshpande A, et al. Opioids compared with placebo or other treatments for chronic low back pain: an update of the Cochrane Review. Spine (Phila Pa 1976) 2014;39:556-563.
45. Oshlack B, Chasin M, Minogue JJ, Kaiko RF. Controlled release oxycodone compositions. https://www.google.ch/patents/US5266331 (date last accessed 16 May 2017).
46. Ausness RC. Role of Litigation in the Fight against Prescription Drug Abuse. West VA Law Rev 2013;116:1117.
47. Meier B. In guilty plea, oxycontin maker to pay $600 million. The New York Times. 2007. http://www.nytimes.com/2007/05/10/business/11drug-web.html (date last accessed 21 March 2017).
48. No authors listed. Federation of State Medical Boards of the US. Model guidelines for the use of controlled substances for the treatment of pain: A policy document of the Federation of State Medical Boards of the United States, Inc. http://www.painpolicy. wisc.edu/sites/www.painpolicy.wisc.edu/files/model-0.pdf (date last accessed 21 March 2017).
49. Kotecha MK, Sites BD. Pain policy and abuse of prescription opioids in the USA: a cautionary tale for Europe. Anaesthesia 2013;68:1210-1215.
50. Brennan F, Carr DB, Cousins M. Pain management: a fundamental human right. Anesth Analg 2007;105:205-221.
51. Cousins MJ, Lynch ME. The Declaration Montreal: access to pain management is a fundamental human right. Pain 2011;152:2673-2674.
52. Campbell JN. APS 1995 presidential address. Pain Forum 1996;5:85-88.
53. Phillips DM. JCAHO pain management standards are unveiled. Joint Commission on Accreditation of Healthcare Organizations. JAMA 2000;284:428-429.
54. Wallace AS, Freburger JK, Darter JD, Jackman AM, Carey TS. Comfortably numb? Exploring satisfaction with chronic back pain visits. Spine J 2009;9:721-728.
55. Yanni LM, McKinney-Ketchum JL, Harrington SB, et al. Preparation, confidence, and attitudes about chronic noncancer pain in graduate medical education. J Grad Med Educ 2010;2:260-268.
56. No authors listed. Missed Opportunity: National Survey Of Primary Care Physicians And Patients On Substance Abuse. New York: Columbia University; 2000.
57. Mezei L, Murinson BB, Johns Hopkins Pain Curriculum Development Team. Pain education in North American medical schools. J Pain 2011;12:1199-1208.
58. Keller CE, Ashrafioun L, Neumann AM, et al. Practices, perceptions, and concerns of primary care physicians about opioid dependence associated with the treatment of chronic pain. Subst Abus 2012;33:103-113.
59. Watt-Watson J, McGillion M, Hunter J, et al. A survey of prelicensure pain curricula in health science faculties in Canadian universities. Pain Res Manag 2009;14:439-444.
60. No authors listed. International Narcotics Control Board (INCB). Opioid Consumption Maps. https://ppsg.medicine.wisc.edu/ (date last accessed 21 March 2017).
61. Florence CS, Zhou C, Luo F, Xu L. The Economic Burden of Prescription Opioid Overdose, Abuse, and Dependence in the United States, 2013. Med Care 2016;54:901-916.
62. No authors listed. Centers for Disease Control and Prevention (CDC). Opioid Painkiller Prescribing. http://www.cdc.gov/vitalsigns/opioid-prescribing/ (date last accessed 21 March 2017).
63. No authors listed. Substance Abuse and Mental Health Services Administration. Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings and Detailed Tables. http://archive.samhsa.gov/data/NSDUH/ 2012SummNatFindDetTables/Index.aspx (date last accessed 21 March 2017).
64. Crane EH. Emergency department visits involving narcotic pain relievers. The CBHSQ Report. Rockville (MD): Substance Abuse and Mental Health Services Administration 2013-2015.
65. No authors listed. IMS Health. National Prescription Audit; Top 25 Medicines by Dispensed Prescriptions (U.S.). https://www.imshealth.com/files/web/Corporate/ News/Top-Line%20Market%20Data/ US-Top-25-Medicines-Dispensed-Prescriptions.pdf (date last accessed 21 March 2017).
66. van Amsterdam J, van den Brink W. The misuse of prescription opioids: a threat for europe? Curr Drug Abuse Rev 2015;8:3-14.
67. No authors listed. WHO's cancer pain ladder for adults. http://www.who.int/cancer/ palliative/painladder/en/ (date last accessed 21 March 2017).
68. Wunsch H, Wijeysundera DN, Passarella MA, Neuman MD. Opioids Prescribed After Low-Risk Surgical Procedures in the United States, 2004-2012. JAMA 2016;315:1654-1657.
69. Mazer-Amirshahi M, Mullins PM, Rasooly I, van den Anker J, Pines JM. Rising opioid prescribing in adult U.S. emergency department visits: 2001-2010. Acad Emerg Med 2014;21:236-243.
70. Daubresse M, Chang HY, Yu Y, et al. Ambulatory diagnosis and treatment of nonmalignant pain in the United States, 2000-2010. Med Care 2013;51:870-878.
71. No authors listed. Centers for Disease Control and Prevention (CDC). Opioid Overdose; Prescribing Data. http://www.cdc.gov/drugoverdose/data/prescribing.html (date last accessed 21 March 2017).
72. Paulozzi LJ. Prescription drug overdoses: a review. J Safety Res 2012;43:283-289.
73. No authors listed. Centers for Disease Control and Prevention (CDC), National Vital Statistics System, Mortality File. Number and age-adjusted rates of drug-poisoning deaths involving opioid analgesics and heroin: United States, 2000-2014. http:// www.cdc.gov/nchs/data/health-policy/ AADR-drug-poisoning-involving-OA-Heroin-US-2000-2014.pdf (date last accessed 21 March 2017).
74. Jones CM. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers - United States, 2002-2004 and 2008-2010. Drug Alcohol Depend 2013;132:95-100.
75. No authors listed. Centers for Disease Control and Prevention (CDC). Vital signs: overdoses of prescription opioid pain relievers, United States, 1999-2008. http:// www.cdc.gov/mmwr/preview/mmwrhtml/mm6043a4.htm (date last accessed 21 March 2017).
76. No authors listed. Centers for Disease Control and Prevention (CDC). Opioid Overdose; Data. http://www.cdc.gov/drugoverdose/data/index.html (date last accessed 21 March 2017).
77. No authors listed. The Pain & Policy Studies Group (PPSG). Opioid Consumption Data. http://www.painpolicy.wisc.edu/opioid-consumption-data (date last accessed 21 March 2017).
78. No authors listed. International Narcotics Control Board (INCB). Narcotic drugs technical report: Estimated world requirements for 2015 - statistics for 2013. https:// www.incb.org/incb/en/narcotic-drugs/Technical-Reports/2016/narcotic-drugs-technical- report-2016.html (date last accessed 21 March 2017).
79. No authors listed. European Monitoring Centre for Drugs and Drug Addiction. Perspectives on drugs; Preventing overdose deaths in Europe. http:// www.emcdda.europa.eu/topics/pods/preventing-overdose-deaths (date last accessed 21 March 2017).
80. No authors listed. Population Reference Bureau (PRB). 2014 World Population Data Sheet. http://www.prb.org/pdf14/2014-world-population-data-sheet-eng.pdf (date last accessed 21 March 2017).
81. No authors listed. Custom Consumption Graphs for Opioid Medicines. https://ppsgchart. medicine.wisc.edu/ (date last accessed 21 March 2017).
82. Ruscitto A, Smith BH, Guthrie B. Changes in opioid and other analgesic use 1995-2010: repeated cross-sectional analysis of dispensed prescribing for a large geographical population in Scotland. Eur J Pain 2015;19:59-66.
83. Scheck J. Tramadol: The Opioid Crisis for the Rest of the World. The Wall Street Journal. 19 October, 2016. https://www.wsj.com/articles/tramadol-the-opioid-crisisfor- the-rest-of-the-world-1476887401 (date last accessed 21 March 2017).
84. Sinikallio S, Aalto T, Airaksinen O, et al. Depression is associated with poorer outcome of lumbar spinal stenosis surgery. Eur Spine J 2007;16:905-912.
85. Teunis T, Bot AG, Thornton ER, Ring D. Catastrophic thinking is associated with finger stiffness after distal radius fracture surgery. J Orthop Trauma 2015;29:414-420.
86. Webster KE, Feller JA, Lambros C. Development and preliminary validation of a scale to measure the psychological impact of returning to sport following anterior cruciate ligament reconstruction surgery. Phys Ther Sport 2008;9:9-15.
87. Julka A, Vranceanu AM, Shah AS, Peters F, Ring D. Predictors of pain during and the day after corticosteroid injection for idiopathic trigger finger. J Hand Surg Am 2012;37:237-242.
88. Anakwe RE, Jenkins PJ, Moran M. Predicting dissatisfaction after total hip arthroplasty: a study of 850 patients. J Arthroplasty 2011;26:209-213.
89. Heck DA, Robinson RL, Partridge CM, Lubitz RM, Freund DA. Patient outcomes after knee replacement. Clin Orthop Relat Res 1998;356:93-110.
90. Vranceanu AM, Barsky A, Ring D. Psychosocial aspects of disabling musculoskeletal pain. J Bone Joint Surg [Am] 2009;91-A:2014-2018.
91. Lindenhovius AL, Helmerhorst GT, Schnellen AC, et al. Differences in prescription of narcotic pain medication after operative treatment of hip and ankle fractures in the United States and The Netherlands. J Trauma 2009;67:160-164.
92. Carragee EJ, Vittum D, Truong TP, Burton D. Pain control and cultural norms and expectations after closed femoral shaft fractures. Am J Orthop (Belle Mead NJ) 1999;28:97-102.
93. Sullivan MJL. The Pain Catastrophizing Scale. http://sullivan-painresearch. mcgill.ca/pdf/pcs/PCSManual-English.pdf (date last accessed 16 May 2017).
94. Weisberg D, Stannard C. Lost in translation? Learning from the opioid epidemic in the USA. Anaesthesia 2013;68:1215-1219.
95. Eriksen J, Sjogren P, Bruera E, Ekholm O, Rasmussen NK. Critical issues on opioids in chronic non-cancer pain: an epidemiological study. Pain 2006;125:172-179.
96. Dhalla IA, Persaud N, Juurlink DN. Facing up to the prescription opioid crisis. BMJ 2011;343:5142.
97. Lee M, Silverman SM, Hansen H, Patel VB, Manchikanti L. A comprehensive review of opioid-induced hyperalgesia. Pain Physician 2011;14:145-161.
98. Angst MS, Clark JD. Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology 2006;104:570-587.
99. Manchikanti L, Vallejo R, Manchikanti KN, et al. Effectiveness of long-term opioid therapy for chronic non-cancer pain. Pain Physician 2011;14:E133-E156.
100. Deyo RA, Von Korff M, Duhrkoop D. Opioids for low back pain. BMJ 2015;350:6380.
101. Menendez ME, Ring D, Bateman BT. Preoperative Opioid Misuse is Associated With Increased Morbidity and Mortality After Elective Orthopaedic Surgery. Clin Orthop Relat Res 2015;473:2402-2412.
102. Ip HY, Abrishami A, Peng PW, Wong J, Chung F. Predictors of postoperative pain and analgesic consumption: a qualitative systematic review. Anesthesiology 2009;111:657-677.
103. Turk DC, Okifuji A. What factors affect physicians' decisions to prescribe opioids for chronic noncancer pain patients? Clin J Pain 1997;13:330-336.
104. Sullivan MD, Howe CQ. Opioid therapy for chronic pain in the United States: promises and perils. Pain 2013;154:S94-S100.
105. Vranceanu AM, Jupiter JB, Mudgal CS, Ring D. Predictors of pain intensity and disability after minor hand surgery. J Hand Surg Am 2010;35:956-960.
106. Teunis T, Thornton ER, Guitton TG, Vranceanu AM, Ring D. Coaching of patients with an isolated minimally displaced fracture of the radial head immediately increases range of motion. J Hand Ther 2016;29:314-319.
107. Wertli MM, Burgstaller JM, Weiser S, et al. Influence of catastrophizing on treatment outcome in patients with nonspecific low back pain: a systematic review. Spine (Phila Pa 1976) 2014;39:263-273.
108. Wertli MM, Eugster R, Held U, et al. Catastrophizing-a prognostic factor for outcome in patients with low back pain: a systematic review. Spine J 2014;14:2639-2657.
109. No authors listed. American Academy of Orthopaedic Surgeons (AAOS). Opioid Use, Misuse, and Abuse in Orthopaedic Practice http://www.aaos.org/uploaded- Files/PreProduction/About/Opinion-Statements/advistmt/ 1045%20Opioid%20Use, %20Misuse, %20and%20Abuse%20in%20Practice.pdf (date last accessed 21 March 2017).
110. Rodgers J, Cunningham K, Fitzgerald K, Finnerty E. Opioid consumption following outpatient upper extremity surgery. J Hand Surg Am 2012;37:645-650.
111. Kim N, Matzon JL, Abboudi J, et al. A Prospective Evaluation of Opioid Utilization After Upper-Extremity Surgical Procedures: Identifying Consumption Patterns and Determining Prescribing Guidelines. J Bone Joint Surg [Am] 2016;98:89.
112. Stanek JJ, Renslow MA, Kalliainen LK. The effect of an educational program on opioid prescription patterns in hand surgery: a quality improvement program. J Hand Surg Am 2015;40:341-346.